|

Prospective Observational Trial to Evaluate Quality of Life After Definitive Chemoradiation in Patients With Anal Cancer (LANACARE)

RECRUITINGSponsored by Ludwig-Maximilians - University of Munich
Actively Recruiting
SponsorLudwig-Maximilians - University of Munich
Started2018-12-01
Est. completion2021-12
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT03792854

Summary

Observational study to evaluate longitudinal quality of life according to standardized EORTC questionaires as well as functional outcome, oncological outcome and toxicity in patients treated with definitive chemoradiation for anal cancer

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* histologically proven anal cancer without distant metastases
* indication for definitive chemoradiation therapy based on multidisciplinary evaluation
* age \>=18 years
* written informed consent
* ability to answer the standardized questionaires according to the treating physician

Exclusion Criteria:

* age \< 18 years
* prior systemic therapy with regard to anal cancer
* distant metastases
* second malignancy

Conditions4

Anal CancerCancerChemoradiationQuality of Life

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.